Profile
AVGR ISRG BDXA BDX ALC RMD
Company Name Avinger, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.52M $183.74B $53.11B $49.57B $44.11B $40.72B
Employees 0.07K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Nabeel P. Subainati CPA Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
AVGR ISRG BDXA BDX ALC RMD
Quant Rating Score 2 3 5 3 3 4
Quant Rating Sell Neutral Strong Buy Neutral Neutral Buy
Trading
AVGR ISRG BDXA BDX ALC RMD
Last Close $0.474 $483.12 $59.24 $176.37 $87.87 $279.2
High 52 $1.45 $610.45 $59.24 $249.08 $100.76 $279.2
Low 52 $0.38 $438 $59.24 $165.15 $82.73 $204.58
Price vs. 52 Week High -67.31 % -20.86 % 0 % -29.19 % -12.79 % 0 %
Price vs. 52 Week Low 24.74 % 10.3 % 0 % 6.79 % 6.21 % 36.47 %
Total Return
AVGR ISRG BDXA BDX ALC RMD
1 Month Return 0 % -10.65 % 0 % -0.51 % -1.6 % 9.09 %
3 Month Return 0 % -8.75 % 0 % 4.5 % -10.61 % 16.36 %
6 Month Return -17.57 % -15.52 % 0 % -28.77 % -3.53 % 18.21 %
9 Month Return -39.23 % -4.59 % 0 % -25.03 % -4.27 % 14.3 %
YTD Return -42.05 % -7.44 % 0 % -22.26 % 3.51 % 22.09 %
1 Year Return -66.14 % 7.42 % 0 % -27.08 % -4.88 % 24.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVGR ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.28 % 2.35 % 0.37 % 0.76 %
Dividend Paid and Capex Coverage Ration (TTM) -223.88 % 2.77 % 1.77 % 1.77 % 3.43 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) -0.35 % - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
AVGR ISRG BDXA BDX ALC RMD
Asset Growth -43.09 % 21.38 % 8.54 % 8.54 % 1.79 %
Gross Profit Growth -24.53 % 19.13 % 11.69 % 11.69 % 12.72 %
Revenue Growth -7.51 % 17.24 % 4.16 % 4.16 % 10.95 %
Revenue 3 Year -81.76 % 46.64 % -0.51 % -0.51 % 44.86 %
Revenue 5 Year -99.56 % 81.77 % 8.72 % 8.72 % 74.97 %
Revenue 10 Year -99.99 % 266.32 % 59.37 % 59.37 % 189.94 %
EBIT Growth -4.25 % 32.95 % 19.82 % 19.82 % 12.75 %
Net Income Growth -5.12 % 29.18 % 14.89 % 14.89 % 13.75 %
Net Income 3 Yeari Growth Per Share 80.7 % 36.6 % -18.63 % -18.63 % 112.66 %
Net Income 5 Yeari Growth Per Share 99.7 % 64.12 % 30.19 % 30.19 % 145.63 %
Net Income 10 Yeari Growth Per Share 100 % 418.52 % -4.02 % -4.02 % 184.54 %
Operating Income Growth -4.25 % 32.95 % 13.55 % 13.55 % 16.61 %
Operating Cash Flow Growth (CFG) 13.89 % 33.15 % 27.07 % 27.07 % 102.11 %
Operating 3 Year CFG 79.69 % 15.88 % -18.4 % -18.4 % 87.99 %
Operating 5 Year CFG 99.65 % 47.28 % 6.25 % 6.25 % 197.13 %
Operating 10 Year CFG 100 % 239.49 % 45.28 % 45.28 % 244.62 %
EPS Growth 44.27 % 27.71 % 18.31 % 18.31 % 13.4 %
EPS Diluted Growth 44.27 % 27.63 % 18.62 % 18.62 % 13.63 %
Book Value Per Share -179.29 % 21.99 % -0.85 % -0.85 % 17.57 %
Share Holder 3 Year Equity Growth Per Share -109.9 % 37.85 % 9.16 % 9.16 % 66.6 %
Share Holder 5 Year Equity Growth Per Share -100.3 % 93.34 % 13.89 % 13.89 % 128.49 %
Share Holder 10 Year Equity Growth Per Share 100 % 354.67 % 241.78 % 241.78 % 166.2 %
Dividend Per Share Growth -100 % - -2.44 % -2.44 % 9.12 %
Dividend 3 Year Growth Per Share -100 % - 4.79 % 4.79 % 23.08 %
Dividend 5 Year Growth Per Share -100 % - 4.14 % 4.14 % 29.8 %
Dividend 10 Year Growth Per Share - - 74.3 % 74.3 % 91.97 %
Debt Growth -5.89 % - 26.65 % 26.65 % -44.68 %
Free Cash Flow Growth 14.1 % 73.93 % 45.25 % 45.25 % 130 %
Updated On 31 Dec 2023 31 Dec 2024 30 Sep 2024 30 Sep 2024 30 Jun 2024
Profitability
AVGR ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 20.94 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM -136.82 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM -5425.36 % 15.52 % 5.86 % 5.86 % 5.22 % 25.18 %
Return on Capital Employed TTM -427.04 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 100 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 106.34 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM -240.98 % 28.2 % 11.33 % 11.33 % 15.24 % 32.1 %
Cash Flow To Debt Ratio TTM -260.09 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 8.28 6.46 6.89 6.89 5.34 5.53
Payables Turnover TTM 6.23 10.39 - - 5.24 9.36
Inventory Turnover TTM 1.53 1.85 3.11 3.11 1.88 2.41
Fixed Asset Turnover TTM 383.62 % 181.6 % 313.98 % 313.98 % 202.43 % 729.93 %
Asset Turnover TTM 53.39 % 45.34 % 38.31 % 38.31 % 32.01 % 66.36 %
Operating Cash Flow Per Share TTM -6.54 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -6.54 4.88 8.98 8.98 3.26 10.66
Cash Per Share TTM 265.33 % 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM -200.39 % 31.34 % 15.81 % 15.81 % 21.17 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 63.9 % 78.51 % 78.51 % 76.82 % 94.64 %
Cash Flow Coverage Ratios TTM -260.09 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -0.1 105.28 19.72 19.14 27.32 26.03
Price To Operating Cash Flows Ratio TTM -0.07 67.1 15.58 15.12 21.01 24.65
Price Cash Flow Ratio TTM -0.07 67.1 15.58 15.12 21.01 24.65
Income Statement (TTM)
AVGR ISRG BDXA BDX ALC RMD
Revenue $0.01B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 26.18% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $-0.02B $2.81B $4.82B $4.82B $2.68B $1.69B
Net Income $-0.02B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted -23.31 6.42 5.86 5.86 2.05 -
Balance Sheet (MRQ)
AVGR ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.02B $2.31B $31.4B $31.4B $8.79B $2.01B
Total Equity $-0.01B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.17B
Total Debt $0.02B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.01B $18.84B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
AVGR ISRG BDXA BDX ALC RMD
Net Income $-0.02B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
DXR Daxor Corporation 9.45
EKSO Ekso Bionics Holdings, Inc. 3.49
FEMY Femasys Inc. 0.8196
GCTK GlucoTrack, Inc. 6.23
ETFs With Exposure to AVGR
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00001 193.64
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00001 146.9
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00001 146.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00001 362.53
Unlock